Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Kidney Disease Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Kidney Disease Drugsmarket, defines the market attractiveness level of Kidney Disease Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Kidney Disease Drugs industry, describes the types of Kidney Disease Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Kidney Disease Drugs market and the development prospects and opportunities of Kidney Disease Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Kidney Disease Drugs market in Chapter 13.
By Player:
Tianjin Tongrentang Group
zhejiang Shengbokang Pharmaceutical
Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
Amgen
AstraZeneca
AbbVie
Kissei Pharmaceutical
Teva Pharmaceutical Industries
Pfizer
Roche
Keryx Biopharmaceuticals
Sanofi
Datong Liqun Pharmaceutical
Changxing Pharmaceutical
GlaxoSmithKline
Hebei Ruisen Pharmaceutical
By Type:
Tablets
Capsule
Other
By End-User:
Chronic Glomerulonephritis
Nephrotic Syndrome
Chronic Renal Failure
Kidney Stones
Renal Cyst (polycystic Kidney)
Diabetic Nephropathy
Hypertensive Nephropathy
Purpura Nephritis
Lupus Nephritis
Pediatric Kidney Disease
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Kidney Disease Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Kidney Disease Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Kidney Disease Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Kidney Disease Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Kidney Disease Drugs Market Analysis and Outlook to 2022
-
7.1 Global Kidney Disease Drugs Consumption (2017-2022)
-
7.2 United States Kidney Disease Drugs Consumption (2017-2022)
-
7.3 Europe Kidney Disease Drugs Consumption (2017-2022)
-
7.4 China Kidney Disease Drugs Consumption (2017-2022)
-
7.5 Japan Kidney Disease Drugs Consumption (2017-2022)
-
7.6 India Kidney Disease Drugs Consumption (2017-2022)
-
7.7 South Korea Kidney Disease Drugs Consumption (2017-2022)
8 Region and Country-wise Kidney Disease Drugs Market Analysis and Outlook to 2028
-
8.1 Global Kidney Disease Drugs Consumption Forecast (2022-2028)
-
8.2 United States Kidney Disease Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Kidney Disease Drugs Consumption Forecast (2022-2028)
-
8.4 China Kidney Disease Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Kidney Disease Drugs Consumption Forecast (2022-2028)
-
8.6 India Kidney Disease Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Kidney Disease Drugs Consumption Forecast (2022-2028)
9 Global Kidney Disease Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Kidney Disease Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Capsule Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Kidney Disease Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chronic Glomerulonephritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Nephrotic Syndrome Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Chronic Renal Failure Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Kidney Stones Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Renal Cyst (polycystic Kidney) Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Diabetic Nephropathy Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Hypertensive Nephropathy Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Purpura Nephritis Consumption and Growth Rate (2017-2022)
-
9.2.9 Global Lupus Nephritis Consumption and Growth Rate (2017-2022)
-
9.2.10 Global Pediatric Kidney Disease Consumption and Growth Rate (2017-2022)
10 Global Kidney Disease Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Kidney Disease Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Kidney Disease Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Chronic Glomerulonephritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Nephrotic Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Chronic Renal Failure Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Kidney Stones Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Renal Cyst (polycystic Kidney) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Diabetic Nephropathy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Hypertensive Nephropathy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.8 Global Purpura Nephritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.9 Global Lupus Nephritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.10 Global Pediatric Kidney Disease Consumption Forecast and Growth Rate (2022-2028)
11 Global Kidney Disease Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Kidney Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Kidney Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Kidney Disease Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Kidney Disease Drugs Market Competitive Analysis
-
14.1 Tianjin Tongrentang Group
-
14.1.1 Tianjin Tongrentang Group Company Details
-
14.1.2 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Tianjin Tongrentang Group Kidney Disease Drugs Product and Service
-
14.2 zhejiang Shengbokang Pharmaceutical
-
14.2.1 zhejiang Shengbokang Pharmaceutical Company Details
-
14.2.2 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product and Service
-
14.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
-
14.3.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Details
-
14.3.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product and Service
-
14.4 Amgen
-
14.4.1 Amgen Company Details
-
14.4.2 Amgen Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen Kidney Disease Drugs Product and Service
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Details
-
14.5.2 AstraZeneca Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Kidney Disease Drugs Product and Service
-
14.6 AbbVie
-
14.6.1 AbbVie Company Details
-
14.6.2 AbbVie Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AbbVie Kidney Disease Drugs Product and Service
-
14.7 Kissei Pharmaceutical
-
14.7.1 Kissei Pharmaceutical Company Details
-
14.7.2 Kissei Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Kissei Pharmaceutical Kidney Disease Drugs Product and Service
-
14.8 Teva Pharmaceutical Industries
-
14.8.1 Teva Pharmaceutical Industries Company Details
-
14.8.2 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Teva Pharmaceutical Industries Kidney Disease Drugs Product and Service
-
14.9 Pfizer
-
14.9.1 Pfizer Company Details
-
14.9.2 Pfizer Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Pfizer Kidney Disease Drugs Product and Service
-
14.10 Roche
-
14.10.1 Roche Company Details
-
14.10.2 Roche Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Roche Kidney Disease Drugs Product and Service
-
14.11 Keryx Biopharmaceuticals
-
14.11.1 Keryx Biopharmaceuticals Company Details
-
14.11.2 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Keryx Biopharmaceuticals Kidney Disease Drugs Product and Service
-
14.12 Sanofi
-
14.12.1 Sanofi Company Details
-
14.12.2 Sanofi Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Sanofi Kidney Disease Drugs Product and Service
-
14.13 Datong Liqun Pharmaceutical
-
14.13.1 Datong Liqun Pharmaceutical Company Details
-
14.13.2 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Product and Service
-
14.14 Changxing Pharmaceutical
-
14.14.1 Changxing Pharmaceutical Company Details
-
14.14.2 Changxing Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Changxing Pharmaceutical Kidney Disease Drugs Product and Service
-
14.15 GlaxoSmithKline
-
14.15.1 GlaxoSmithKline Company Details
-
14.15.2 GlaxoSmithKline Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 GlaxoSmithKline Kidney Disease Drugs Product and Service
-
14.16 Hebei Ruisen Pharmaceutical
-
14.16.1 Hebei Ruisen Pharmaceutical Company Details
-
14.16.2 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Kidney Disease Drugs
-
Figure Kidney Disease Drugs Picture
-
Table Global Kidney Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney Disease Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Kidney Disease Drugs Consumption by Country (2017-2022)
-
Figure United States Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Capsule Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Glomerulonephritis Consumption and Growth Rate (2017-2022)
-
Figure Global Nephrotic Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Renal Failure Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Stones Consumption and Growth Rate (2017-2022)
-
Figure Global Renal Cyst (polycystic Kidney) Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetic Nephropathy Consumption and Growth Rate (2017-2022)
-
Figure Global Hypertensive Nephropathy Consumption and Growth Rate (2017-2022)
-
Figure Global Purpura Nephritis Consumption and Growth Rate (2017-2022)
-
Figure Global Lupus Nephritis Consumption and Growth Rate (2017-2022)
-
Figure Global Pediatric Kidney Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Glomerulonephritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nephrotic Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Renal Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Stones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renal Cyst (polycystic Kidney) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetic Nephropathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypertensive Nephropathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Purpura Nephritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lupus Nephritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pediatric Kidney Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Kidney Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Kidney Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Tianjin Tongrentang Group (Foundation Year, Company Profile and etc.)
-
Table Tianjin Tongrentang Group Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tianjin Tongrentang Group Kidney Disease Drugs Product and Service
-
Table zhejiang Shengbokang Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product and Service
-
Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Kidney Disease Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Kidney Disease Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Kidney Disease Drugs Product and Service
-
Table Kissei Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Kissei Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kissei Pharmaceutical Kidney Disease Drugs Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Kidney Disease Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Kidney Disease Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Kidney Disease Drugs Product and Service
-
Table Keryx Biopharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Keryx Biopharmaceuticals Kidney Disease Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Kidney Disease Drugs Product and Service
-
Table Datong Liqun Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Datong Liqun Pharmaceutical Kidney Disease Drugs Product and Service
-
Table Changxing Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Changxing Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Changxing Pharmaceutical Kidney Disease Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Kidney Disease Drugs Product and Service
-
Table Hebei Ruisen Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product and Service
-
